66. IgA腎症 IgA nephropathy Clinical trials / Disease details

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

27 trials found

diseases per page:

Showing 1 to 10 of 27 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003308-14-FI (EUCTR)	22/02/2021	27/10/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	Belarus;United States;Czechia;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic ...
2	EUCTR2020-003308-14-GR (EUCTR)	03/12/2020	26/10/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	Belarus;United States;Czechia;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech R ...
3	EUCTR2020-003308-14-PL (EUCTR)	24/11/2020	01/10/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	United States;Belarus;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic; ...
4	EUCTR2020-003308-14-FR (EUCTR)	13/11/2020	13/10/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	United States;Belarus;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic; ...
5	EUCTR2020-003308-14-GB (EUCTR)	12/11/2020	21/10/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	United States;Belarus;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic; ...
6	EUCTR2020-003308-14-IT (EUCTR)	12/11/2020	24/05/2021	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: [Nefecon] INN or Proposed INN: BUDESONIDE	CALLIDITAS THERAPEUTICS AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	Belarus;United States;Czechia;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech R ...
7	EUCTR2020-003308-14-SE (EUCTR)	21/10/2020	18/09/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	United States;Belarus;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic; ...
8	EUCTR2020-003308-14-CZ (EUCTR)	21/10/2020	16/09/2020	Study in which Efficacy and Safety of Nefecon is Evaluated in Patients With IgA Nepropathy Who Have ...	An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Pati ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 3	United States;Belarus;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic; ...
9	EUCTR2017-004902-16-IT (EUCTR)	16/11/2018	20/01/2021	A study in which the safety and efficacy of Nefecon is compared with placebo in patients with primar ...	A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in P ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: [Nefecon] INN or Proposed INN: BUDESONIDE	CALLIDITAS THERAPEUTICS AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 3	Belarus;Czechia;Taiwan;Greece;Finland;Spain;Turkey;United Kingdom;Italy;France;Czech Republic;Canada ...
10	EUCTR2017-004902-16-PL (EUCTR)	27/08/2018	18/07/2018	A study in which the safety and efficacy of Nefecon is compared with placebo in patients with primar ...	A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in P ...	Primary IgA nephropathy patients at risk of developing end stage renal disease MedDRA version: 20.0; ...	Product Name: Nefecon Product Code: Nefecon INN or Proposed INN: BUDESONIDE Other descriptive name: Nef ...	Calliditas Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 3	Argentina;Poland;Belgium;Australia;Germany;China;Sweden;Korea, Republic of;Belarus;United States;Cze ...

First Previous1 2 3Next Last